Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher, Gentel Team on 96-Well Microarray Platform

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific and Gentel Biosciences have completed the first phase of a collaboration on a product offering that will increase the speed and volume of multiplex microarray technologies, the companies said Thursday.
 
The partners said the new platform, offered by Thermo Scientific as the SmartPlex and by Gentel under the APiX 96 name, conforms to the SBS microplate standard and may be used to help process “thousands of samples per day.”
 
“Now that multiplex immunoassays have come of age, higher throughput configurations of the technology are a natural step in providing the next generation of analytical tools for protein measurements,” said Gentel VP of Commercial Operations Randy Durnell.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.